Publication:
Cellular Targets of Propranolol in Infantile Hemangioma

Thumbnail Image

Date

2014-02-25

Authors

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lee, Daniel K. 2014. Cellular Targets of Propranolol in Infantile Hemangioma. Doctoral dissertation, Harvard University.

Research Data

Abstract

Infantile hemangioma (IH) is a vascular neoplasm that affects 4-10 percent of infants. Propranolol, a non-selective beta-adrenergic receptor (AR) antagonist, was serendipitously discovered to accelerate regression of IH in 2008; however, its mechanism in IH is unclear.

Description

Other Available Sources

Keywords

Biology

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories